Long-term survival and immunological parameters in metastatic melanoma patients who responded to ipilimumab 10 mg/kg within an expanded access programme

被引：0
|
作者：
Anna Maria Di Giacomo
Luana Calabrò
Riccardo Danielli
Ester Fonsatti
Erica Bertocci
Isabella Pesce
Carolina Fazio
Ornella Cutaia
Diana Giannarelli
Clelia Miracco
Maurizio Biagioli
Maresa Altomonte
Michele Maio
机构：
[1] University Hospital of Siena,Division of Medical Oncology and Immunotherapy, Department of Oncology, Istituto Toscano Tumori
[2] Regina Elena National Cancer Institute,Statistical Unit
[3] University Hospital of Siena,Department of Pathology
[4] University Hospital of Siena,Department of Dermatology
来源：
Cancer Immunology, Immunotherapy | 2013年 / 62卷
关键词：
Biomarker; Expanded access programme; Ipilimumab; Long-term survival; Metastatic melanoma;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1021 / 1028
页数：7
相关论文
共 50 条
  • [41] Clinical Factors Associated with Long-Term Survival in Metastatic Melanoma Treated with Anti-PD1 Alone or in Combination with Ipilimumab
    Goutam, Siddhartha
    Stukalin, Igor
    Ewanchuk, Benjamin
    Sander, Michael
    Ding, Philip Q.
    Meyers, Daniel E.
    Heng, Daniel
    Cheung, Winson Y.
    Cheng, Tina
    CURRENT ONCOLOGY, 2022, 29 (10) : 7695 - 7704
  • [42] Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma
    Schadendorf, Dirk
    Hodi, F. Stephen
    Robert, Caroline
    Weber, Jeffrey S.
    Margolin, Kim
    Hamid, Omid
    Patt, Debra
    Chen, Tai-Tsang
    Berman, David M.
    Wolchok, Jedd D.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (17) : 1889 - U48
  • [43] Long-term survival and outcome of patients originally given Mycobacterium vaccae for metastatic malignant melanoma
    Cananzi, Ferdinando C. M.
    Mudan, Satvinder
    Dunne, Mary
    Belonwu, Nneka
    Dalgleish, Angus G.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2013, 9 (11) : 2427 - 2433
  • [44] Long-term survival of patients with metastatic melanoma (MM) treated with dacarbazine (DTIC) or temozolomide (TMZ)
    Kim, C.
    Lee, C. W.
    Klasa, R.
    Shah, A.
    Savage, K. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [45] Association of plasma exosomal mRNA changes with long-term durable response to ipilimumab (IPI) in metastatic melanoma (MM) patients
    Coticchia, Christine M.
    Sullivan, Ryan J.
    Hurley, James D.
    Hu, Lan
    Lawrence, Donald P.
    Flaherty, Keith
    Blackmon, Shauna M.
    Brock, Graham
    O'Neill, Vincent J.
    Skog, Johan
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [46] IPILIMUMAB IMPROVES OVERALL SURVIVAL IN PATIENTS WITH PREVIOUSLY TREATED, ADVANCED MELANOMA: LONG-TERM SURVIVAL RESULTS FROM A PHASE III TRIAL
    Haanen, J. B.
    Hodi, F. S.
    O'Day, S. J.
    McDermott, D. F.
    Robert, C.
    Schadendorf, D.
    van den Eertwegh, A. J.
    Chen, T.
    Hoos, A.
    Urba, W. J.
    ANNALS OF ONCOLOGY, 2010, 21 : 402 - 402
  • [47] Long-term survival of patients after ipilimumab and hypofractionated brain radiotherapy for brain metastases of malignant melanoma: sequence matters
    Schmidberger, Heinz
    Rapp, Matthias
    Ebersberger, Anne
    Hey-Koch, Silla
    Loquai, Carmen
    Grabbe, Stephan
    Mayer, Arnulf
    STRAHLENTHERAPIE UND ONKOLOGIE, 2018, 194 (12) : 1144 - 1151
  • [48] Long-Term Survival After Stereotactic and Hypofractionated Radiation Therapy in Patients With Metastatic Melanoma Brain Metastases
    Casey, D. L.
    Yamada, Y.
    Chan, T. A.
    Yang, T. J.
    Wolchok, J. D.
    Postow, M. A.
    Brennan, C. W.
    Tabar, V. S.
    Gutin, P. H.
    Beal, K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E67 - E67
  • [49] Long-term survival in metastatic melanoma patients treated with sequential biochemotherapy: Report of a phase II study
    Neri, B.
    Vannozzi, L.
    Fulignati, C.
    Pantaleo, P.
    Pantalone, D.
    Paoletti, C.
    Perfetto, F.
    Turrini, M.
    Mazzanti, R.
    CANCER INVESTIGATION, 2006, 24 (05) : 474 - 478
  • [50] IPILIMUMAB IN THE DAILY PRACTICE: FEASIBILITY, SAFETY, EFFICACY AND LONG-TERM FOLLOW-UP IN HEAVILY PRETREATED METASTATIC MELANOMA PATIENTS
    Di Giacomo, Anna Maria
    Danielli, Riccardo
    Calabro, Luana
    Bertocci, Erica
    Nannicini, Chiara
    Miracco, Clelia
    Biagioli, Maurizio
    Mazzei, Maria Antonietta
    Altomonte, Maresa
    Maio, Michele
    ANNALS OF ONCOLOGY, 2009, 20
12345